RKLB Rebounds as Its CFO Flips the SpaceX IPO From Threat Into a Neutron Tailwind

The Reframe

The bounce has a name attached to it. At the Wells Fargo Industrials & Materials Conference on June 10, CFO Adam Spice argued that SpaceX's pivot toward Starlink, Starship and space-based data centers — and away from competing hard for commercial launch — leaves Neutron 'a very nice spot in this market going forward' once it can scale. RKLB had closed Wednesday at $105.05, down 3%; it has since clawed back to $115.70, up 13.30%.

What makes this worth flagging is that it inverts the trade from a week ago. Less than six days back, the SpaceX IPO was the thing *draining* RKLB — the proxy premium leaking out as the real listing approached and hedge funds organized short exposure. Spice's pitch hands the bulls a counter-narrative: SpaceX going public and leaning into Starlink doesn't crowd Rocket Lab out, it vacates the medium-lift commercial lane Neutron is being built to fill. Whether that's analysis or a CFO talking his book a day before SPCX prices, it was enough to turn a capitulation low into a 13% session.

Two Launches and an IPO in 48 Hours

The reframe is landing into an unusually dense event window. Rocket Lab has a classified hypersonic test mission called Curveball on the pad at NASA's Wallops Flight Facility, with a June 11 launch window, flying on the HASTE variant of Electron — part of a $190 million Department of Defense hypersonic program and the first HASTE flight of 2026 supported by Wallops.

Then the main event: SpaceX prices after Thursday's close and debuts Friday, June 12 under the ticker SPCX. The irony is hard to miss — the proxy bid is re-establishing in RKLB *right before* SPCX gives space-sector bulls and bears a direct instrument. The same logic that says capital rotated into RKLB to play SpaceX cuts the other way once SPCX trades. This bounce is happening on borrowed time unless the Neutron story stands on its own. Worth noting for perps specifically: the HIP-3 RKLB book is thin, turning over roughly $6.8M in 24 hours, so a stock already moving 13% intraday can gap hard against shallow depth.

What's Actually Underneath

Strip out the proxy mechanics and the fundamentals are genuinely strong. Q1 2026 revenue hit a record $200.3 million, up 63.5% year over year, with non-GAAP gross margin at 43%, and management guided Q2 to $225–240 million against a $205 million consensus. Backlog stands at $2.2 billion, up 108% year over year, anchored by an $816 million Space Development Agency award and the $190 million HASTE contract. Stifel carries the street-high $132 target, raised from $110 on June 4, and the May close of the Mynaric acquisition adds laser-comms hardware to the stack.

The caveat is valuation and positioning. The stock is up roughly 370% year-to-date, printed an all-time high of $151 on May 27, and trades well above most analyst targets — while insiders sold about $18 million into the parabola. Neutron's first flight is still only targeted for year-end after a February booster-tank rupture, so the 'nice spot' thesis is optionality, not revenue. This bounce is real, but it's leaning on a launch, a narrative, and an IPO that all resolve inside 48 hours.